Knightsbridge Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,600
Closed -$266K 86
2021
Q2
$266K Hold
1,600
0.1% 59
2021
Q1
$291K Hold
1,600
0.12% 55
2020
Q4
$320K Hold
1,600
0.16% 42
2020
Q3
$351K Hold
1,600
0.2% 39
2020
Q2
$305K Buy
+1,600
New +$280K 0.2% 36

Other funds holding TDOC

Knightsbridge Asset Management's TDOC Position: Q3 2021 in Review

Knightsbridge Asset Management sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 1,600 shares — an estimated $266K sold.

Knightsbridge Asset Management first reported a position in TDOC in Q2 2020 and held it in 5 quarters. The position peaked at $351K in Q3 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

  • Knightsbridge Asset Management reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
  • Knightsbridge Asset Management sold 1,600 Teladoc Health shares in Q3 2021, an estimated $266K.
  • Knightsbridge Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 5 quarters.
  • Knightsbridge Asset Management's Teladoc Health position peaked at $351K in Q3 2020.
  • 761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Knightsbridge Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.